Secure your place at the Digiday Media Buying Summit in Nashville, March 2-4
Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
Future of Marketing Briefing: AI’s branding problem is why marketers keep it off the label
The reputational downside is clearer than the branding upside, which makes discretion the safer strategy.
While holdcos build ‘death stars of content,’ indie creative agencies take alternative routes
Indie agencies and the holding company sector were once bound together. The Super Bowl and WPP’s latest remodeling plans show they’re heading in different directions.
How Boll & Branch leverages AI for operational and creative tasks
Boll & Branch first and foremost uses AI to manage workflows across teams.